Just diagnosed with Lysosomal acid lipase deficiency?
You are not alone. Here is where to start: learn the basics, find a specialist or center that sees Lysosomal acid lipase deficiency, look for clinical trials, and connect with others living with it — all in one place.
Open the full interactive Lysosomal acid lipase deficiency hub →Overview
Lysosomal acid lipase deficiency is a rare condition. Also known as LAL deficiency, LALD. Tomeko brings together the specialists, research, clinical trials, treatments and community for Lysosomal acid lipase deficiency so you can go from overwhelmed to oriented. For authoritative medical detail, see the reference sources below.
Identifiers: ORPHA:275761 · OMIM 278000 · ICD-10 E75.5 · GARD 0012097
Find care for Lysosomal acid lipase deficiency
Authoritative references for Lysosomal acid lipase deficiency
Research & market landscape for Lysosomal acid lipase deficiency
Following Lysosomal acid lipase deficiency for research or industry? Tomeko brings together the recruiting trials, the latest literature, patient organizations, and the specialist and care-center footprint for Lysosomal acid lipase deficiency — the real-world landscape behind the condition, in one place.
- Latest Lysosomal acid lipase deficiency research on PubMed ↗
- Recruiting Lysosomal acid lipase deficiency trials on ClinicalTrials.gov ↗
- Explore the Lysosomal acid lipase deficiency research & specialist footprint on Tomeko
Researchers, patient organizations & industry: Tomeko provides de-identified, no-PHI demand and engagement signal, trial awareness, and a labeled, editorially-firewalled presence for Lysosomal acid lipase deficiency and every rare condition. See how Tomeko works with industry →
Common questions
What is Lysosomal acid lipase deficiency?
Lysosomal acid lipase deficiency is a rare condition. Also known as LAL deficiency, LALD. For an authoritative medical description see the reference sources on this page; Tomeko brings the specialists, clinical trials, patient organizations and community for Lysosomal acid lipase deficiency together in one place.
What are the symptoms of Lysosomal acid lipase deficiency?
Symptoms of Lysosomal acid lipase deficiency vary from person to person. For a reviewed, plain-language overview see the authoritative references below (NIH GARD, Orphanet), and discuss your own symptoms with a clinician who treats Lysosomal acid lipase deficiency.
How is Lysosomal acid lipase deficiency treated?
Treatment for Lysosomal acid lipase deficiency depends on the individual and is managed by specialists. Use Tomeko to find clinicians and Centers of Excellence who see Lysosomal acid lipase deficiency, and review current options with them.
What causes Lysosomal acid lipase deficiency — is it genetic?
The cause and inheritance of Lysosomal acid lipase deficiency are described in the authoritative references linked on this page. A genetics or specialist clinician who treats Lysosomal acid lipase deficiency can explain what it means for you and your family.
I was just diagnosed with Lysosomal acid lipase deficiency — what should I do first?
Start by learning the basics from an authoritative source, find a specialist or center that sees Lysosomal acid lipase deficiency, and connect with a patient organization. Tomeko brings these together on one hub.
Where can I find a specialist for Lysosomal acid lipase deficiency?
Use Tomeko's specialist and Centers-of-Excellence directories to find clinicians who treat Lysosomal acid lipase deficiency, filtered to your area.
Are there clinical trials for Lysosomal acid lipase deficiency?
Tomeko shows live, recruiting studies for Lysosomal acid lipase deficiency from ClinicalTrials.gov on the hub.
Related conditions
Other conditions on Tomeko you may be looking for:
- 2-aminoadipic 2-oxoadipic aciduria
- 3 beta-Hydroxysteroid dehydrogenase deficiency
- 3-hydroxy-3-methylglutaryl-CoA synthase deficiency
- 3-Hydroxyisobutyric aciduria
- 3-hydroxyisobutyryl-CoA hydrolase deficiency
- 3-methylglutaconic aciduria type 1
- 3-Methylglutaconic aciduria type 2
- 3-Methylglutaconic aciduria type 3